as 11-15-2024 4:00pm EST
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
Founded: | 2009 | Country: | United States |
Employees: | N/A | City: | WOBURN |
Market Cap: | 4.7M | IPO Year: | 2021 |
Target Price: | N/A | AVG Volume (30 days): | 954.4K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -17.63 | EPS Growth: | N/A |
52 Week Low/High: | $3.41 - $12.60 | Next Earning Date: | 11-07-2024 |
Revenue: | $10,390,702 | Revenue Growth: | 0.74% |
Revenue Growth (this year): | 13.82% | Revenue Growth (next year): | 11.76% |
ISPC Breaking Stock News: Dive into ISPC Ticker-Specific Updates for Smart Investing
Newsfile
10 days ago
GlobeNewswire
11 days ago
GlobeNewswire
11 days ago
GlobeNewswire
17 days ago
MT Newswires
19 days ago
GlobeNewswire
19 days ago
GlobeNewswire
2 months ago
TipRanks
2 months ago
The information presented on this page, "ISPC iSpecimen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.